R2810-ONC-1788 |TROG 17.11 cPOST: A randomised, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous (#36)
Danny Rischin
1
- Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia
Content is not available at the time of publishing.